Correlation Between Relief Therapeutics and Cell Source

Can any of the company-specific risk be diversified away by investing in both Relief Therapeutics and Cell Source at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relief Therapeutics and Cell Source into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Relief Therapeutics Holding and Cell Source, you can compare the effects of market volatilities on Relief Therapeutics and Cell Source and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relief Therapeutics with a short position of Cell Source. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relief Therapeutics and Cell Source.

Diversification Opportunities for Relief Therapeutics and Cell Source

0.31

Correlation Coefficient

Relief Therapeutics  Cell Source

Weak diversification

The 3 months correlation between Relief and Cell is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Relief Therapeutics Holding and Cell Source in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Source and Relief Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relief Therapeutics Holding are associated (or correlated) with Cell Source. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Source has no effect on the direction of Relief Therapeutics i.e., Relief Therapeutics and Cell Source go up and down completely randomly.

Pair Corralation between Relief Therapeutics and Cell Source

Assuming the 90 days horizon Relief Therapeutics Holding is expected to under-perform the Cell Source. But the otc stock apears to be less risky and, when comparing its historical volatility, Relief Therapeutics Holding is 2.02 times less risky than Cell Source. The otc stock trades about -0.04 of its potential returns per unit of risk. The Cell Source is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  57.00  in Cell Source on December 21, 2024 and sell it today you would lose (27.00) from holding Cell Source or give up 47.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Relief Therapeutics Holding  vs.  Cell Source

Relief Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Relief Therapeutics Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cell Source

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cell Source has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Relief Therapeutics and Cell Source

The main advantage of trading using opposite Relief Therapeutics and Cell Source positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relief Therapeutics position performs unexpectedly, Cell Source can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Source will offset losses from the drop in Cell Source's long position.

The idea behind Relief Therapeutics Holding and Cell Source pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.